SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astrazeneca Pharma India informs about board meeting

04 Aug 2020 Evaluate

Astrazeneca Pharma India has informed that a meeting of the Board of Directors of the company will be held on Monday, August 10, 2020 to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30, 2020 and consider declaration of an Interim Dividend to the equity shareholders of the Company for the financial year 2020-21. The company has informed that the ‘Trading Window’ remains closed for all Designated Persons, from June 16, 2020 to August 12, 2020 in terms of the company Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8435.50 -13.90 (-0.16%)
24-Apr-2026 12:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.00
Dr. Reddys Lab 1345.00
Cipla 1300.00
Zydus Lifesciences 931.05
Lupin 2277.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×